DSD-T015
Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T015
Classic 11β-hydroxylase deficiency (CYP11B1 W116C homozygous), detected by second-tier LC-MS/MS in newborn screening.
Case fields and evidence
- Category
-
Congenital adrenal hyperplasia (CAH)
- Age
-
Neonate (newborn screening blood spot at 36 hours of life, recalled at 10 days of life).
- Sex
-
Male (full-term male infant).
- Karyotype
-
46,XY
- Diagnosis
-
Classic 11β-hydroxylase deficiency (CYP11B1 W116C homozygous), detected by second-tier LC-MS/MS in newborn screening.
- Follow-up
-
Not reported in the original.
- General phenotype
-
Male neonate; external genital phenotype not described in detail in the original; early diagnosis can prevent precocious puberty, accelerated bone age, and hypertension.
- Imaging
-
Not reported in the original.
- Laboratory findings
-
Immunoassay 17-OHP 72.8 nmol/l; LC-MS/MS 17-OHP 13.2/6.3/12.3 nmol/l (normal), 11-deoxycortisol 525/324/1,188 nmol/l (reference <8.60), cortisol 11.4/14.6/14.1 nmol/l (low), androstenedione 39.6 nmol/l, testosterone 5.2 nmol/l, DOC 5.0 nmol/l (16.8 after ACTH stimulation).
- Management
-
Early hydrocortisone treatment to prevent precocious puberty, accelerated bone age, and hypertension (the original states the rationale for treatment; specific doses not reported).
- Pathology
-
Not reported in the original.
- Evidence level
-
See source
- Clinical history
-
See source
- Family history
-
See source
- Puberty / Tanner
-
See source
- Limitations
-
See source
Cite this resource
DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T015 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T015?version=v1.4.0